NEW YORK (GenomeWeb) – Meridian Bioscience today reported its first quarter revenues rose 12 percent, with growth in both its life sciences and diagnostics businesses somewhat offset by losses in its Magellan lead testing unit.

For the three months ended Dec. 31, 2017, revenues increased to $52.3 million from $46.8 million a year ago, beating Wall Street analysts' average estimate of $49.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.